Why Small Biotech Companies Can Be Mispriced
Small biotechnology companies are often valued around a handful of uncertain events. That uncertainty can create both opportunity and substantial risk.
Notes on biotechnology, artificial intelligence, and the overlooked public companies where those fields meet.
If you would like to discuss our research or investment approach, get in touch.